ZACCARELLI, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 417
EU - Europa 197
AS - Asia 104
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 726
Nazione #
US - Stati Uniti d'America 405
SE - Svezia 100
CN - Cina 35
SG - Singapore 33
IN - India 32
IT - Italia 28
FI - Finlandia 18
RO - Romania 14
CA - Canada 12
DE - Germania 10
GB - Regno Unito 9
FR - Francia 6
UA - Ucraina 5
JP - Giappone 3
AT - Austria 2
EG - Egitto 2
IE - Irlanda 2
TG - Togo 2
AR - Argentina 1
CZ - Repubblica Ceca 1
EU - Europa 1
ID - Indonesia 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 726
Città #
Ashburn 50
Fairfield 50
Chandler 37
Woodbridge 30
Cambridge 27
Singapore 21
Beijing 19
Wilmington 17
Houston 16
Ann Arbor 14
Plano 14
Princeton 14
Seattle 12
Ottawa 10
Santa Clara 10
Millbury 9
San Paolo di Civitate 8
Lawrence 6
Norwalk 6
Boston 4
Los Angeles 4
Washington 4
Dallas 3
Dearborn 3
Hamadacho 3
Helsinki 3
Mumbai 3
Rome 3
Andover 2
Bühl 2
Cairo 2
Dublin 2
Grafing 2
Hefei 2
Kunming 2
Lomé 2
London 2
Redwood City 2
San Diego 2
Southend 2
Toronto 2
Auckland 1
Bangalore 1
Bremen 1
Brno 1
Chengdu 1
Chiswick 1
Des Moines 1
Dossenheim 1
Falkenstein 1
Federal 1
Frankfurt am Main 1
Fremont 1
Guangzhou 1
Horia 1
Jakarta 1
Jinhua 1
L'aquila 1
Leawood 1
Mannheim 1
Monmouth Junction 1
Moscow 1
Nanchang 1
Newark 1
Paris 1
Pune 1
Riga 1
Shenyang 1
Silverton 1
Silvi 1
Vienna 1
Wuhan 1
Zhengzhou 1
Totale 458
Nome #
Breast cancer during pregnancy 82
Triple-negative breast cancer: investigating potential molecular therapeutic target 78
Nonpegylated liposomal doxorubicin (nPLD) in neoadjuvant treatment of local advanced breast cancer (LABC) patients (pts) 58
null 55
BODY MASS INDEX (BMI) AND AMENORRHEA IN PREMENOPAUSAL BREAST CANCER PATIENTS (PBC) TREATED WITH ADJUVANT ANTRACYCLINE AND CYCLOPHOSPAMIDE CHEMOTHERAPY (CT) 53
EFFICACY AND SAFETY PROFILES OF PEGFILGRASTIM (P) AND LENOGRASTIM (L) IN NON METASTATIC BREAST CANCER (NMBC) PATIENTS RECEIVING ADJUVANT FEC100 49
null 48
null 45
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer 44
Plerixafor and autologous stem cell transplantation: Impressive result in a chemoresistant testicular cancer patient treated with high-dose chemotherapy 40
null 33
KRAS genotypes and outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab. 32
null 29
Primary prophylaxis of neutropenia in women affected by breast cancer undergoing adjuvant chemotherapy with fec 100+/- docetaxel. Comparison of efficacy and tolerability between lenograstim and pegfilgrastim 25
Bevacizumab in ovarian cancer: A critical review of phase III studies 23
Incidence of chemotherapy (CT) induced amenorrhea in premenopausal patients (pts) with breast cancer (BC) following adjuvant anthracycline (A), cyclophosphamide (C), and taxane (T) 23
Targeting angiogenesis in endometrial cancer - New agents for tailored treatments 21
null 20
Efficacy, safety and cost-effectiveness (ce) analysis of lenograstim (l) versus pegfilgrastim (p) in management of chemotherapy related neutropenia (crn) in non metastatic breast cancer (bc) patients 19
Totale 777
Categoria #
all - tutte 2.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.421


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202099 0 0 0 0 0 13 18 18 18 15 9 8
2020/202148 11 7 2 3 4 6 0 3 4 7 0 1
2021/2022159 0 2 10 14 32 12 5 6 14 10 25 29
2022/2023179 41 51 15 4 24 11 13 5 12 0 3 0
2023/202477 3 9 9 5 14 16 0 4 1 6 5 5
2024/202563 2 5 18 8 18 12 0 0 0 0 0 0
Totale 777